Host intestinal and immune system

The host intestinal and immune system is a complex physiological environment rather than a single molecular target. It encompasses the intestinal epithelium, the gut microbiota, and the gut-associated lymphoid tissue (GALT), which serves as the primary site for immune surveillance and tolerance induction (Mowat & Agace, Nature Reviews Immunology, 2014). This system maintains a critical homeostatic balance, protecting the host from pathogens while preventing overreaction to commensal bacteria and food antigens. When this balance is disrupted, it leads to chronic immune-mediated diseases such as Crohn's disease and ulcerative colitis (Danese & Fiocchi, New England Journal of Medicine, 2011). While the system itself is not a single target, it contains numerous specific therapeutic targets like TNF-alpha, IL-23, and alpha-4-beta-7 integrin. Understanding the interplay within this system is essential for developing biologics and small molecules that treat chronic gastrointestinal inflammation and promote mucosal healing (Neurath, Nature Reviews Immunology, 2014).

Other names

Gut-associated lymphoid tissueGALTIntestinal mucosal immune systemGut-immune axisMucosal immune system

Drugs acting within this system typically modulate specific molecular pathways such as TNF-alpha signaling (e.g., infliximab), leukocyte trafficking via integrins (e.g., vedolizumab), or cytokine signaling through Janus kinases (e.g., tofacitinib) to reduce pathological inflammation and restore mucosal healing (Sandborn et al., New England Journal of Medicine, 2017; Neurath, Nature Reviews Immunology, 2014).